loader image
Tuesday, December 9, 2025
46.9 F
McAllen
- Advertisement -

LEARN MORE ABOUT DR. BILAL BIN HAFEEZ

Translate to Spanish or other 102 languages!

Graduate research assistants Emmanuel Anning, Godwin Peasah-Darkwah and Asif Shahriar work in the lab to assist in the development of a treatment for advanced pancreatic cancer. (UTRGV Image Office of Research & New Program Development)

Mega Doctor News

- Advertisement -

Hafeez is the founding member of the first nationally recognized South Texas Center of Excellence in Cancer Immunology at the UTRGV School of Medicine and is an accomplished researcher with a background in immunopharmacology, cancer therapeutics and cancer biology. Hafeez, a Nehtaur, Bijnor, Uttar Pradesh, India native, has earned prestigious grant awards and is an active member of the American Association for Cancer Research and the Indian Association for Cancer Research. His significant contributions to cancer biology and molecular therapeutics have led to his numerous published manuscripts in scientific journals. 

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

‘Troopers, Toys & Teddy Bears’ Holiday Drive, Thru Dec. 21st

Mega Doctor News For millions around the world, the Christmas season is considered “the most...

STHS McAllen Hosting 40th Anniversary Community Celebration, Dec. 11th

For the last 40 years, South Texas Health System (STHS) McAllen has stood tall in the South Texas skyline, serving as a beacon of healing and hope for the residents of McAllen and the greater Rio Grande Valley.

DHR Health Awarded Large Employer of the Year by Texas Workforce Commission

Workforce Solutions Lower Rio Grande Valley (WFS) proudly announced that its nominee, DHR Health, has been awarded the Large Employer of the Year Award at the 28th Annual Texas Workforce Commission (TWC) Conference.

ACIP: Parents to Decide on Hepatitis B Vaccine for Infants

The Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) today voted 8 to 3 to recommend individual-based decision-making for parents deciding whether to give the hepatitis B vaccine, including the birth dose, to infants born to women who test negative for the virus.
- Advertisement -
×